Shrilla Banerjee, MD, FRCP, consultant cardiologist, Surrey and Sussex Healthcare NHS Trust, shares what politicians and clinical trialists can do to help mitigate cardiovascular health disparities.
Shrilla Banerjee, MD, FRCP, consultant cardiologist, Surrey and Sussex Healthcare NHS Trust, describes the social determinants of health (SDOH) that she sees contributing to cardiovascular health disparities in the United Kingdom and what politicians and clinical trialists can do to help mitigate these issues.
Transcript
What are some SDOH that further contribute to cardiovascular health disparities, and what strategies might mitigate their impact on health outcomes?
There are some changes that need to be implemented by politicians. We need to advocate for our patients and lobby politicians to improve living conditions, minimum wage, and the expectation of access to food for school children. It's something that doesn't strike me on a regular basis, because it's not something I'm exposed to, but we have children in schools in the UK who don't eat a proper meal apart from when they go to school.
So, in fact, if we gave [food] access to all school children, it wouldn't be a huge cost but it would improve the quality of life and the lived experience of children from minority populations and from more deprived populations—it's not only minority populations. And it would improve their health care and then their well-being as they go into adulthood, because if you have poor health care nutrition in childhood, it often leads to poor health outcomes as an adult as well.
So there's lots of things we can think about on an institutional level, but on a personal level, obviously addressing your own bias. We need to make sure that our patients who have more economic challenges are encouraged to enroll in clinical trials and be supportive in that way as well.
We perhaps need to make a quota in research. We're suggesting that now for women. Women are often 20% or 30% of clinical trial participants when they're 50%, 52% of the population. So why isn't it 50/50? Certain conditions impact women at a later age, so if there's an age cutoff, you can understand that there may be less women in the age group being randomized. But actually it's not difficult to find more mixed populations, and I think we need to encourage that. If you encourage trialists to enroll more people of color, then I think we'll get more relevant data.
A new federal rule will enable thousands of immigrants in the Deferred Action for Childhood Arrivals (DACA) program to obtain health care through the Affordable Care Act; a forthcoming CMS rule is expected to lower home-based care wait times and raise caregiver wages; the HHS Office for Civil Rights has finalized 2 rules that strengthen the ACA’s health care discrimination ban.
Read More
Tackling Health Inequality: The Power of Education and Experience
April 30th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our final episode of this limited series and our conversation with Janine Jelks-Seale, MSPPM, director of health equity at UPMC Health Plan.
Listen
Shelly Lanning on How Employers Can Reduce Costs by Bridging Gaps in Women's Health Care
May 3rd 2024In a presentation at the Greater Philadelphia Business Coalition on Health Women’s Health Summit, Shelly Lanning, cofounder and president of Visana Health, addressed the need for comprehensive approaches in women’s health care and their coverage options.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Industry Experts Tackle Specialty Drug Access Challenges for Employer Benefit Plans
May 2nd 2024Representatives from ICON plc and Symphony Health joined forces at AXS24 to discuss the challenges of managing high-cost specialty drugs and how they influence self-funded employer benefit plan design and employee access to specialty medications.
Read More